Tongat ali for testosterone boosting , any evidence of organ damage?
Reading Document
Medical Text Search
Tongkat Ali Eurycoma longifolia testosterone boosting efficacy clinical evidence
Medical Text Search
Tongkat Ali Eurycoma longifolia organ toxicity liver kidney damage safety
GradeResponse
GradeResponse
No results from the in-house database. Drawing from established pharmacological and clinical literature below.
Tongkat Ali (Eurycoma longifolia) — Testosterone Boosting & Organ Safety
Mechanism of Action
Tongkat Ali contains bioactive quassinoids (eurycomanone, eurycomaoside) and peptides believed to:
- Stimulate the hypothalamic-pituitary-gonadal (HPG) axis
- Inhibit sex hormone-binding globulin (SHBG), increasing free testosterone
- Reduce cortisol, indirectly supporting testosterone levels
Evidence for Testosterone Boosting
| Study Type | Finding | Quality |
|---|---|---|
| RCT (Tambi et al., 2012 — Andrologia) | 200 mg/day standardized extract for 1 month in late-onset hypogonadal men → significant increase in total testosterone (from ~5.7 to ~8.4 nmol/L) | Moderate (small n=76) |
| RCT (Henkel et al., 2014) | Improved sperm motility and testosterone in men with idiopathic infertility | Moderate |
| Pilot study (Talbott et al., 2013) | 200 mg/day in stressed adults → reduced cortisol ~16%, increased testosterone ~37% | Low (n=63, no placebo arm) |
| Systematic review (Leisegang et al., 2021 — Phytotherapy Research) | Majority of trials show modest but consistent testosterone elevation, primarily in hypogonadal or stressed men; effects smaller in eugonadal men | Moderate overall |
Key takeaway: There is modest, consistent evidence for testosterone elevation in men with below-normal or low-normal testosterone. Effects in healthy eugonadal men are less convincing. Most trials use 200 mg/day of a standardized water-soluble extract (TA-10% or similar).
Evidence on Organ Damage
Liver
- Preclinical (rodent) data: High-dose extracts (>200 mg/kg/day in rats) have shown hepatotoxic changes — elevated ALT/AST, hepatocellular degeneration — particularly with crude or non-standardized preparations containing high quassinoid concentrations.
- Clinical data: At standard doses (200–400 mg/day standardized extract), published human trials and safety studies have not reported significant hepatotoxicity. Liver function tests (LFTs) in RCTs remained within normal limits.
- Case reports: Sporadic reports exist of liver enzyme elevation with unregulated or high-dose supplement use, though causality is difficult to establish due to polypharmacy and unlabeled ingredients.
Kidney
- Preclinical studies show no significant nephrotoxicity at therapeutic doses.
- High-dose animal studies (>500 mg/kg) have demonstrated mild tubular changes, not replicated at human-equivalent doses.
- No clinical case reports of Tongkat Ali-specific renal failure in peer-reviewed literature.
Other Organs / General Safety
- A 28-day toxicity study (standardized extract, Phytotherapy Research, 2006) found no adverse effects on hematology, biochemistry, or organ histology at doses up to 600 mg/day equivalent in humans.
- Mercury contamination is a documented concern: some Malaysian Tongkat Ali products have been found to contain elevated mercury levels (>0.5 ppm), which poses real risks of nephrotoxicity and neurotoxicity. This is a product quality issue, not an intrinsic plant effect.
- A WHO-cited Malaysian health authority review flagged multiple adulterated products, reinforcing the need for third-party-tested, standardized preparations.
Summary
| Concern | Evidence |
|---|---|
| Testosterone elevation | Modest-to-moderate evidence, especially in hypogonadal/stressed men |
| Liver damage (therapeutic dose) | Not demonstrated in clinical trials; risk increases with high doses or crude extracts |
| Kidney damage (therapeutic dose) | Not demonstrated at human-equivalent doses |
| Heavy metal (mercury) toxicity | Real risk from unregulated products — a regulatory/quality issue |
| Long-term safety data | Limited — most trials are ≤12 weeks |
Clinical Bottom Line
At 200–400 mg/day of a quality-standardized extract, Tongkat Ali appears to have a reasonable short-term safety profile with no evidence of clinically significant organ damage. The biggest real-world risk is contaminated or adulterated products rather than the plant itself. Long-term (>3 months) human safety data remain sparse, so caution is warranted in individuals with pre-existing liver or kidney disease.
Note: This is for informational purposes. Individuals considering supplementation, especially with existing medical conditions or medications, should consult a physician.
This is a shared conversation. Sign in to Orris to start your own chat.